| Key Financial Ratios of Ajanta Pharma (in Rs. Cr.) |
Mar 20 |
Mar 19 |
Mar 18 |
Mar 17 |
Mar 16 |
|
| Per Share Ratios |
|
|
|
|
|
|
| Basic EPS (Rs.) |
50.55 |
44.51 |
48.59 |
56.79 |
47.10 |
|
| Diluted EPS (Rs.) |
50.55 |
44.51 |
48.58 |
56.78 |
47.10 |
|
| Cash EPS (Rs.) |
60.71 |
52.64 |
54.79 |
63.23 |
51.69 |
|
| Book Value [ExclRevalReserve]/Share (Rs.) |
280.65 |
244.25 |
218.37 |
170.03 |
127.17 |
|
| Book Value [InclRevalReserve]/Share (Rs.) |
280.65 |
244.25 |
218.37 |
170.03 |
127.17 |
|
| Dividend / Share(Rs.) |
13.00 |
9.00 |
0.00 |
13.00 |
8.00 |
|
| Revenue from Operations/Share (Rs.) |
250.45 |
202.12 |
206.37 |
203.99 |
175.44 |
|
| PBDIT/Share (Rs.) |
81.75 |
66.52 |
70.08 |
79.30 |
67.63 |
|
| PBIT/Share (Rs.) |
71.34 |
58.55 |
63.62 |
72.57 |
62.81 |
|
| PBT/Share (Rs.) |
69.86 |
58.50 |
63.59 |
72.43 |
62.33 |
|
| Net Profit/Share (Rs.) |
50.30 |
44.67 |
48.33 |
56.51 |
46.86 |
|
| Profitability Ratios |
|
|
|
|
|
|
| PBDIT Margin (%) |
32.64 |
32.90 |
33.95 |
38.87 |
38.54 |
|
| PBIT Margin (%) |
28.48 |
28.96 |
30.82 |
35.57 |
35.79 |
|
| PBT Margin (%) |
27.89 |
28.94 |
30.81 |
35.50 |
35.52 |
|
| Net Profit Margin (%) |
20.08 |
22.10 |
23.42 |
27.70 |
26.71 |
|
| Return on Networth / Equity (%) |
17.92 |
18.28 |
22.13 |
33.23 |
36.84 |
|
| Return on Capital Employed (%) |
24.30 |
23.18 |
28.25 |
41.78 |
35.67 |
|
| Return on Assets (%) |
14.46 |
15.53 |
18.65 |
28.58 |
29.29 |
|
| Total Debt/Equity (X) |
0.00 |
0.00 |
0.00 |
0.00 |
0.05 |
|
| Asset Turnover Ratio (%) |
72.03 |
70.29 |
79.64 |
103.19 |
109.67 |
|
| Liquidity Ratios |
|
|
|
|
|
|
| Current Ratio (X) |
2.98 |
3.42 |
3.65 |
3.65 |
2.76 |
|
| Quick Ratio (X) |
2.06 |
2.07 |
2.59 |
2.81 |
2.01 |
|
| Inventory Turnover Ratio (X) |
5.04 |
4.28 |
5.75 |
10.06 |
8.18 |
|
| Dividend Payout Ratio (NP) (%) |
25.71 |
20.22 |
0.00 |
22.89 |
16.98 |
|
| Dividend Payout Ratio (CP) (%) |
21.30 |
17.15 |
0.00 |
20.45 |
15.39 |
|
| Earnings Retention Ratio (%) |
74.29 |
79.78 |
0.00 |
77.11 |
83.02 |
|
| Cash Earnings Retention Ratio (%) |
78.70 |
82.85 |
0.00 |
79.55 |
84.61 |
|
| Valuation Ratios |
|
|
|
|
|
|
| Enterprise Value (Cr.) |
11,893.72 |
9,000.74 |
12,395.63 |
15,547.01 |
12,502.72 |
|
| EV/Net Operating Revenue (X) |
5.42 |
5.08 |
6.79 |
8.62 |
8.06 |
|
| EV/EBITDA (X) |
16.59 |
15.43 |
20.00 |
22.17 |
20.90 |
|
| MarketCap/Net Operating Revenue (X) |
5.46 |
5.10 |
6.81 |
8.63 |
8.04 |
|
| Retention Ratios (%) |
74.28 |
79.77 |
0.00 |
77.10 |
83.01 |
|
| Price/BV (X) |
4.87 |
4.22 |
6.44 |
10.35 |
11.09 |
|
| Price/Net Operating Revenue |
5.46 |
5.10 |
6.81 |
8.63 |
8.04 |
|
| Earnings Yield |
0.04 |
0.04 |
0.03 |
0.03 |
0.03 |
|
Source : Dion Global Solutions Limited
